Unofficial traders are making huge pre-listing bets as retail investors chase listing gains, but the unregulated ecosystem of GMP is far from foolproof
Every evening in Mumbai and Ahmedabad’s mobile streets, a peculiar ritual unfolds. Men huddle over mobile phones, scribbling numbers on scraps of paper, trading shares that don’t officially exist yet. Welcome to India’s grey market — a multi-billion rupee back economy where Initial Public Offerings are bought and sold days before they hit the stock exchange.
The grey market premium has evolved from insider whisper network to mainstream obsession. Retail investors now routinely check GMP — the unofficial markup over issue price — before deciding whether to apply for an IPO. Modern Diagnostic’s small SME offering saw its grey premium gyrate between Rs 12 and Rs 16 in just 72 hours this week, a wild swing that would make cryptocurrency traders blush.
This isn’t your grandfather’s stock market. There are no exchanges, no regulators, no written contracts. Just phone calls, trust between strangers, and bundles of cash changing hands in nondescript offices. Settlement happens on listing day at 9.45 am sharp, with dealers punching buy-sell orders based on handwritten ledgers and Excel sheets. Miss a payment and you’re out of the ecosystem forever — reputation is the only collateral that matters.
The mechanics are straightforward but risky. Say Company X prices its IPO at Rs 100. If grey market operators are quoting Rs 30 premium, the implied listing price becomes Rs 130. Investors can sell their applications before allotment for a fixed “kostak” rate, or wait for allotment and sell for a higher “subject to sauda” price. The system lets nimble traders lock in profits without waiting for listing day, but it also exposes novices to fraud in an ecosystem with zero legal recourse.
Research suggests the grey market gets it right roughly 84 per cent of the time, based on studies tracking hundreds of Indian IPOs. That’s impressive for an unregulated bazaar operating entirely on gut feel and gossip. Yet the 16 per cent miss rate tells cautionary tales. High-profile offerings have seen premiums of Rs 70-80 per share evaporate before listing, leaving grey market punters nursing heavy losses.
The SME segment has become ground zero for grey market mania. These small company listings — often raising just Rs 20-30 crore — combine tiny issue sizes with oversized lot requirements, creating artificial scarcity. An SME IPO might see 50,000 retail applications competing for just 800 allotments. That’s lottery-level odds, which perversely makes grey market trading even more frenzied as disappointed applicants try to get exposure through unofficial channels.
Market veterans point to deeper structural issues. Grey market premiums often reflect operator-driven demand rather than genuine investor appetite. Small issue sizes mean a handful of traders can artificially inflate premiums, creating the appearance of strong demand that pulls in retail investors. Once the listing happens and selling begins, prices can crater as quickly as they rose.
The January IPO calendar illustrates the dynamic perfectly. Bharat Coking Coal is commanding Rs 13-14 premiums despite analyst estimates suggesting fair value closer to Rs 22-25 at current pricing. That’s grey market optimism running well ahead of fundamentals. The premium represents nearly 60 per cent markup on the expected offer price, a figure that looks increasingly disconnected from the company’s actual earnings trajectory and peer valuations in the coal sector.
The contradiction at the heart of India’s grey market is this: it exists because IPO allotment is uncertain and listing gains are tempting, but its existence may be fueling the very overvaluation and subsequent underperformance that makes investors seek grey market guidance in the first place. It’s a self-reinforcing loop where speculation breeds more speculation.
Yet here’s the rub: grey market premiums are only as good as the information feeding them. Dealers base quotes on subscription trends, anchor investor interest, overall market sentiment, and their own book positions. None of these factors necessarily correlate with what a company is actually worth or how it will perform post-listing. An IPO can be 100 times oversubscribed and still list flat if institutional investors decide the pricing is stretched.
The ecosystem’s unregulated nature cuts both ways. It provides real-time price discovery that official channels don’t, filling a genuine market need during the days between IPO close and listing. But the same lack of oversight that makes it nimble also makes it vulnerable to manipulation. A few large operators quoting aggressive premiums can create FOMO that pulls retail money into questionable offerings.
Consider the typical retail investor journey. She sees an IPO announced, checks grey market premium on one of dozens of websites tracking GMP, finds a Rs 50 premium on Rs 150 shares suggesting 33 per cent listing gains, and applies without reading the prospectus. The premium becomes a substitute for due diligence, which is precisely the wrong way to use it.
Smart investors treat GMP as one data point among many. High premium on a fundamentally sound company with reasonable valuation? That’s confirmation of quality. High premium on a loss-making startup with no clear path to profitability? That’s a red flag suggesting retail exuberance divorced from reality. Low or negative premium on a solid business? Potential opportunity if the market is being overly cautious.
What grey market premiums definitely aren’t: guarantees. The unofficial nature means quoted prices can be stale, manipulated, or simply wrong. Regional variations exist — Ahmedabad dealers might quote different premiums than Mumbai counterparts based on local order flow. And premiums can swing wildly in the 24 hours before listing as new information emerges or market sentiment shifts.
The biggest limitation is timing. Grey market trading intensifies in the final days before listing when subscription data is known and allotment is confirmed. But by then, retail investors have already applied and paid for shares. The premium becomes useful for deciding whether to hold or sell on listing day, not whether to apply in the first place — though that doesn’t stop investors from checking GMP before applying and treating it as gospel.
There’s also survivor bias in the 84 per cent accuracy figure. The study tracks IPOs that actually listed. What about the dozens of offerings that get pulled or postponed when grey market reception is poor? Those never make it to the data set, skewing the apparent predictive power upward.
For retail investors navigating IPO season, the lesson is clear: grey market premiums may be just sentiment indicators, not crystal balls, and have to be taken with a pinch of salt. They reflect what traders think might happen, not what will happen. A Rs 50 GMP today can become Rs 0 tomorrow or Rs 80 by listing day, depending on market whims and order flow dynamics entirely invisible to outsiders.
The smart approach is treating grey market data as supporting evidence, never as primary justification. Read the prospectus, understand the business, check peer valuations, assess management quality, and gauge market conditions. Then, if grey market premiums confirm your positive thesis, apply with eyes open. If GMP is the only reason you’re interested, walk away.
India’s Rs 2.5 lakh crore IPO pipeline for 2026 will generate plenty of grey market excitement. Some premiums will prove prescient, others wildly off the mark. The difference between profiting and losing in this shadow market isn’t access to better premium data — everyone sees the same numbers. It’s having the discipline to see the GMP as a tool rather than a crutch – and the wisdom to know when the market’s enthusiasm has crossed the line into delusion.
